Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1430306/000161577418011277/s113412_8k.htm
February 2023
February 2023
January 2023
January 2023
January 2023
January 2023
January 2023
January 2023
January 2023
December 2022
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1430306/000161577418011277/s113412_8k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Tonix Pharmaceuticals Holding Corp..
Tonix Pharmaceuticals Holding Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Tonix Pharmaceuticals Holding Corp. provided additional information to their SEC Filing as exhibits
Ticker: TNXPEvents:
CIK: 1430306
Form Type: 8-K Corporate News
Accession Number: 0001615774-18-011277
Submitted to the SEC: Wed Oct 24 2018 4:05:23 PM EST
Accepted by the SEC: Wed Oct 24 2018
Period: Thursday, October 18, 2018
Industry: Pharmaceutical Preparations